Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Nilotinib in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in blast crisis (CML-BC) who are resistant or intolerant to imatinib.

Giles FJ, Larson RA, Kantarjian HM, le Coutre P, Palandri F, Haque A, Gallagher N, Ottmann OG. Nilotinib in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in blast crisis (CML-BC) who are resistant or intolerant to imatinib. J Clin Oncol. 2008 May 20; 26(15_suppl):7017.

View in: PubMed

collapse authors with profiles